GlaxoSmithKline plcLondon, United Kingdom (NYSE: GSK)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

GlaxoSmithKline Financial Statements

GlaxoSmithKline Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

GlaxoSmithKline Income Statement

  2008 2007 2006
Revenue ($ mil.) 35,244.6 45,347.9 45,479.2
Gross Profit ($ mil.) 25,960.2 34,733.6 35,668.6
Operating Income ($ mil.) 10,857.6 15,778.0 15,887.3
Total Net Income ($ mil.) 6,819.7 10,408.7 10,552.7
Diluted EPS (Net Income) 2.55 3.74 3.70
More GlaxoSmithKline financial information

GlaxoSmithKline Stock Quote & Chart

11/06/09 16:01:45 EST • NYSE • 40.52 • Increased by +0.0600 • Increased by +0.1483 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

GlaxoSmithKline Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.29 2.65 7.00
Price/Earnings Ratio 12.45 16.81 25.45
Price/Book Ratio 7.43 2.88 6.74
Price/Cash Flow Ratio 8.06 10.14 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed GlaxoSmithKline Financial Ratios

GlaxoSmithKline Competitive Intelligence

Novartis Pfizer Sanofi-Aventis
Annual Sales ($ mil.) 42,584.0 48,296.0 40,057.0
Employees 96,717 81,800 98,213
Market Cap ($ mil.) 119,419.7 114,870.4 97,482.8

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy